| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8674181 | Molecular Metabolism | 2018 | 30 Pages |
Abstract
The pathways that confer ASCVD protection for women are of potential therapeutic relevance. Despite protection relative to men, ASCVD is still the major cause of mortality in women. Additionally, diabetic women have similar ASCVD risk as diabetic men, suggesting that the presence of diabetes may offset the protective cardiovascular effects of being female through unknown mechanisms.
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
Brian T. Palmisano, Lin Zhu, Robert H. Eckel, John M. Stafford,